Kenneth A. Getz | Tufts Centre for the Study of Drug Development
Kenneth A. Getz is the Director of Sponsored Research and an associate professor at the Tufts Center for the Study of Drug Development, Tufts University School of Medicine where he directs research programs on drug development management strategy and practice including protocol design and execution; outsourcing; investigative site management; and patient recruitment and retention. He is the chair of CISCRP – a nonprofit organization that he founded to educate and raise public and patient awareness of the clinical research enterprise. Ken is also the founder of CenterWatch, a leading publisher in the clinical trials industry.
A well-known speaker at conferences, symposia, universities, investor meetings and corporations, Ken has published extensively in peer-review journals, books and in the trade press. He is the author of two nationally recognized books for patients and their advocates and the recipient of several awards for innovation and scholarship. Ken has held board appointments in the private and public sectors including serving on the Institute of Medicine’s Clinical Research Roundtable, the Drug Information Association, the Consortium to Examine Clinical Research Ethics, the Clinical Trials Transformation Initiative, the Metrics Champion Consortium, and the WIRB-Copernicus Group. He is on the editorial boards of Pharmaceutical Medicine and Therapeutic Innovation and Regulatory Science, and writes a bi-monthly column in Applied Clinical Trials that was nominated for a Neal Award. Ken has also been nominated twice for Tufts University’s Distinguished Service award and was inducted as a DIA Fellow in 2015.
Ken holds an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University and a bachelor’s degree, Phi Beta Kappa, from Brandeis University. Prior to founding CenterWatch in 1994, Ken worked for over seven years in management consulting where he assisted biopharmaceutical companies develop and implement business strategies to improve clinical development performance.